Val, Cynthia Brant, Fátima Miranda, Aline Rodrigues, Flávia Oliveira, Bruno Santos, Elândia Assis, Diego Esper, Lísia Silva, Bruno Rachid, Milene Tanowitz, Herbert Teixeira, Antônio Teixeira, Mauro Régis, Wiliam Machado, Fabiana MOESM6 of Effect of mushroom Agaricus blazei on immune response and development of experimental cerebral malaria Additional file 6. Fraction C treated mice did not display clinical signs of CM and significant differences in haematrocrit during P. berghei infection. C57BL/6 mice were treated with fraction C of A. blazei or chloroquine three days before infection, then infected with 105 pRBCs, and treated until 7 dpi. (A) clinical signs of cerebral malaria assessed by the RMCBS score and (B) haematocrit assessed on 5th dpi, normalized relative to that of uninfected controls for each mouse group. RMCBS score and haematocrit values were expressed as mean ± SD of 5 mice per group. ***p < 0.001, ANOVA followed Bonferroni’s test. Agaricus blazei Murrill;Experimental cerebral malaria;Immunomodulation;Anti-malarial therapy 2015-08-11
    https://springernature.figshare.com/articles/figure/MOESM6_of_Effect_of_mushroom_Agaricus_blazei_on_immune_response_and_development_of_experimental_cerebral_malaria/4360211
10.6084/m9.figshare.c.3610247_D6.v1